https://biotechmorning.com/news/summit-therapeutics-500m-offering-canceled Biotech Morning en 2026-06-13T14:24:31.070Z Summit Therapeutics Tried to Raise $500M. It Lasted One Day. https://biotechmorning.com/news/glp1-pregnancy-exposure-harvard-study Biotech Morning en 2026-06-13T14:23:42.764Z Millions of Women Take Ozempic. What Happens If They Get Pregnant? https://biotechmorning.com/news/whoop-fda-blood-pressure-fight Biotech Morning en 2026-06-13T14:22:53.242Z Whoop Just Picked a Fight With the FDA. It Might Not Win. https://biotechmorning.com/news/amgen-tavneos-fda-withdrawal-duke-review Biotech Morning en 2026-06-13T14:21:59.544Z Amgen's $3.7 Billion Drug Is About to Face a Jury of Scientists https://biotechmorning.com/news/wegovy-oral-pill-uk-mhra-approval Biotech Morning en 2026-06-13T14:21:09.459Z Wegovy Just Ditched the Needle in the UK https://biotechmorning.com/news/cms-locks-in-medicare-drug-price-negotiations Biotech Morning en 2026-06-13T14:20:22.748Z CMS Just Made Big Pharma's Worst Nightmare Harder to Wake Up From https://biotechmorning.com/news/roche-nurix-btk-degrader-bexobrutideg-deal Biotech Morning en 2026-06-13T14:19:25.588Z Roche Just Paid $700M Upfront for a Drug That Destroys Its Target https://biotechmorning.com/news/lilly-retatrutide-sleep-apnea-phase-3 Biotech Morning en 2026-06-13T14:18:29.866Z Lilly's Next Obesity Drug Might Kill Your CPAP Machine https://biotechmorning.com/news/roche-enicepatide-obesity-weight-loss-trial Biotech Morning en 2026-06-13T14:17:41.467Z Roche Just Crashed the Obesity Party With a Number Nobody Expected https://biotechmorning.com/news/fda-war-cheap-ozempic-knockoffs Biotech Morning en 2026-06-13T14:16:50.643Z The FDA Just Declared War on Cheap Ozempic Knockoffs https://biotechmorning.com/news/heartseed-catheter-ipsc-heart-failure-first-patient Biotech Morning en 2026-06-12T14:25:58.234Z A Catheter, Some Stem Cells, and a Bet on Regrowing the Human Heart https://biotechmorning.com/news/takeda-zasocitinib-beats-sotyktu-psoriasis-2 Biotech Morning en 2026-06-12T14:25:01.341Z Takeda's $4 Billion Bet on a Pill Just Paid Off in a Big Way https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-to-zepbound-2 Biotech Morning en 2026-06-12T14:24:09.576Z Novo Nordisk Just Lost the Obesity Drug Fight It Couldn't Afford to Lose https://biotechmorning.com/news/roche-tecentriq-colon-cancer-priority-review Biotech Morning en 2026-06-12T14:23:10.158Z Roche Just Jumped the Line in Colon Cancer's Biggest Shake-Up in Years https://biotechmorning.com/news/slate-medicines-130m-pacap-migraine-bet Biotech Morning en 2026-06-12T14:22:15.588Z The $130M Bet That CGRP Isn't the Last Word on Migraines https://biotechmorning.com/news/novo-nordisk-new-ceo-doustdar-comeback-plan Biotech Morning en 2026-06-12T14:21:18.846Z Novo Nordisk's New CEO Has a Plan. Wall Street Isn't Sure It Believes Him. https://biotechmorning.com/news/ideaya-eye-cancer-combo-hits-endpoint Biotech Morning en 2026-06-12T14:20:17.970Z The Eye Cancer That Had Almost No Options Just Got One https://biotechmorning.com/news/fda-declared-war-on-cheap-ozempic Biotech Morning en 2026-06-12T14:19:25.334Z The FDA Just Declared War on Cheap Ozempic https://biotechmorning.com/news/genentech-fires-vishva-dixit-gred-restructuring Biotech Morning en 2026-06-12T14:18:32.235Z Genentech Just Fired a Scientific Legend. That Tells You Everything.